Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.10.0.1
Subsequent Events (Details) - USD ($)
 1 Months Ended
Aug. 02, 2018
Jul. 06, 2018
Jul. 05, 2018
Jun. 07, 2018
Dec. 27, 2017
Subsequent Events (Textual)          
Aggregate principal amount       $ 550,000  
Proceeds from issuence of loan         $ 5,750,000
Loan payable         $ 350,000
Related Parties Notes [Member]          
Subsequent Events (Textual)          
Aggregate principal amount       $ 550,000  
Date of maturity       Dec. 06, 2018  
Excess of equity financing       $ 10,000,000  
Subsequent Events [Member]          
Subsequent Events (Textual)          
Aggregate principal amount     $ 500,000    
Excess of equity financing   $ 10,000,000      
Loan additional amount $ 1,700,000        
Subsequent Events [Member] | January 5, 2019 [Member]          
Subsequent Events (Textual)          
Interest rate, percentage     12.00%    
Excess of equity financing     $ 10,000,000    
Subsequent Events [Member] | Loan Parties Notes [Member]          
Subsequent Events (Textual)          
Aggregate principal amount     500,000    
Subsequent Events [Member] | Related Parties Notes [Member]          
Subsequent Events (Textual)          
Aggregate principal amount     $ 200,000    
Subsequent Events [Member] | Loan Agreement [Member]          
Subsequent Events (Textual)          
Aggregate principal amount   $ 6,100,000      
Date of maturity   Jul. 06, 2019      
Interest rate, percentage   8.00%      
Warrants to purchase of common stock shares   5,000,358      
Warrants exercise price   $ 2.00      
Warrants to purchase common stock, description   The Arosa Loan remains outstanding, the Company will be required to issue additional warrants to purchase common stock to Arosa equal to 10% of any additional issuance excluding issuances under an approved stock plan. The additional warrants to purchase common Stock will have an exercise price equal to the lesser of $2.00 or a 5% premium to the price utilized in such financing. Pursuant to the warrant, Arosa may not exercise such warrant if such exercise would result in Arosa beneficially owning in excess of 9.99% of the Company’s then issued and outstanding common stock.